Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cervomed Inc (CRVO)

Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cervomed Inc 20 Park Plaza Suite 424 Boston Boston MA 02216 USA

www.cervomed.com Employees: 8 P: 617-744-4400

Description:

CervoMed Inc. is a clinical-stage biotechnology company advancing CNS-focused therapeutics for patients with a range of degenerative diseases of the brain. The Company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant which inhibits p38MAP kinase alpha. CervoMed Inc., formerly known as Diffusion Pharmaceuticals Inc., is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 49,241
Enterprise Value, $K 41,451
Shares Outstanding, K 6,170
Annual Sales, $ 7,140 K
Annual Net Income, $ -2,170 K
Last Quarter Sales, $ 1,940 K
Last Quarter Net Income, $ -4,750 K
EBIT, $ -9,570 K
EBITDA, $ -9,780 K
60-Month Beta 1.63
% of Insider Shareholders 36.30%
% of Institutional Shareholders 25.15%
Float, K 3,931
% Float 63.70%
Short Volume Ratio 0.67

Growth:

1-Year Return -4.53%
3-Year Return -69.59%
5-Year Return -77.12%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.82%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -1.23
EPS Growth vs. Prev Qtr -103.70%
EPS Growth vs. Prev Year 21.43%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-3 on 08/17/23

CRVO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.11%
Return-on-Assets % -39.81%
Profit Margin % -30.39%
Debt/Equity 0.00
Price/Sales 6.89
Price/Cash Flow N/A
Price/Book 1.30
Book Value/Share 7.40
Interest Coverage -0.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar